Silencing of transgene expression in mammalian cells by DNA methylation and histone modifications in gene therapy perspective

Biotechnol Genet Eng Rev. 2019 Apr;35(1):1-25. doi: 10.1080/02648725.2018.1551594. Epub 2018 Dec 4.

Abstract

DNA methylation and histone modifications are vital in maintaining genomic stability and modulating cellular functions in mammalian cells. These two epigenetic modifications are the most common gene regulatory systems known to spatially control gene expression. Transgene silencing by these two mechanisms is a major challenge to achieving effective gene therapy for many genetic conditions. The implications of transgene silencing caused by epigenetic modifications have been extensively studied and reported in numerous gene delivery studies. This review highlights instances of transgene silencing by DNA methylation and histone modification with specific focus on the role of these two epigenetic effects on the repression of transgene expression in mammalian cells from integrative and non-integrative based gene delivery systems in the context of gene therapy. It also discusses the prospects of achieving an effective and sustained transgene expression for future gene therapy applications.

Keywords: DNA methylation; gene therapy; histone modification; transgene repression.

Publication types

  • Review

MeSH terms

  • Animals
  • DNA Methylation*
  • Gene Silencing
  • Genetic Therapy
  • Histone Code*
  • Humans
  • Promoter Regions, Genetic
  • Transgenes*